Alcidion Group to List on ASX Monday

26th February 2016

Alcidion Group Limited (ASX:ALC) will commence trading on the ASX on Monday, 29th February 2016.

Alcidion provides clinical informatics software that alerts clinicians to emerging clinical risk and streamlines the delivery of care through technology.

Alcidion’s Miya platform integrates disparate Clinical Computer Systems into a single platform to provide a holistic view of a patient and delivers this clinical intelligence to the care team via mobile tablets.

By providing clinicians with decision support tools and prompting care guidance in accordance with hospital approved clinical protocols, patient clinical outcomes may be improved.

Unique Opportunity To Be Part Of The New Digital Health Economy. The introduction of the Patient Protection & Affordable Care Act 2010 (“Obamacare”) requires US hospitals to accelerate the adoption of Electronic Medical Records (EMR). Alcidion Group Limited (ASX:ALC) is a leading supplier of these systems in Australia and is seeking to expand its operations into the United States.

Capable and Experienced Management Teamwith a strong track record of commercializing healthcare software, including the former CEO & Chairman of the South Australian Health Commission, a Stanford qualified Medical Doctor and a former Ernst & Young “Entrepreneur of the Year”.

Proven Technology: Alcidion’s platform is installed into 11 large tertiary hospitals including Footscray, Sunshine, Williamstown, Royal Darwin & Alice Springs Hospitals and throughout Tasmania. Alcidion has invested over $AUD15m in the development of the Miya Platform and product suite.

Disruptive Technology Platform:The platform is at the forefront of medical technology, on the crest of the next generation of healthcare technologies. The Patient Protection & Affordable Care Act 2010, requires US hospitals to adopt Electronic Medical Records or face a reduction in Medicare reimbursements.

Exceptional Customer Relationships,Sticky customer base that provides significant recurring contract revenue of the ongoing licensing, support & maintenance.

Strong Growth Platform: The business recently secured a $1.75m contract with the Northern Territory Health Department to roll out a pilot of the Computerized Physician Order Entry technology with several new contracts being negotiated with leading public and private hospitals throughout Australia and New Zealand. The Clinical Decision Support Systems Market is set to grow from $USD1.18b in 2013 to $USD4.65b by 2018.

Fully Funded: The recent RTO of Naracoota Resources, will see the company full funded, with in excess of $7.00m in cash and debt free.

Click below to watch the Overview Video